Obermatt
See Similar Stocks →

Flags

Earnings warning

Quanterix

NMQ:QTRX · US74766Q1013
Life Sciences Tools & ServicesSmall

360

43
Profit price41
Owner Earnings Yield1
Dividend Yield1
Price/Sales93
EV / Gross Profit95
Price/Book83
Return on Capital14
Cash Return on Capital14
Return on Equity26
EBIT Margin20
Gross Profitability52
Accruals73
Owner Earnings Margin16
Sales growth85
Profit growth45
Reinvestment71
Price momentum17
Debt load70
Refinancing96
Debt Payback1
Liquidity75
Analyst ratings1
Opinion Changes50
Price Target Upside73
Market mood28
Value Creation4/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Quanterix doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
TypePublic Company
ExchangeNASDAQGM
Founded2007
Employees360
Websitequanterix.com
ISINUS74766Q1013
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
Health DiagnosticsImmunologyBiomedical EngineeringNeurologyInflammationNeuroscienceOncologyBiotechnologyHealth CareLife ScienceMedical Device

Description

Quanterix Corporation (Quanterix) is a life sciences entity transforming healthcare innovation by accelerating biomarker breakthroughs from discovery to diagnostics using its ultra-sensitive translational research and spatial biology instruments, con…

Analysis

Middle-of-the-road

Quanterix Corporation is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

Valuation data is not available for this company.

The trajectory is moderate and the balance sheet is adequate. The company scores 4/20 on our value-creation score: not creating value.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
82
2023202420252026

All-time high

82

Jun 2026

All-time low

5

Jan 2023

Average rank

41

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
93
74
13
29
Price/Earnings
49
28
28
28
Price/Book
83
84
46
86
Dividend Yield
1
1
1
1
Value (overall)
86
77
18
61

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Quanterix with its peers
Revvity
NYQ:RVTY
52
CountryUSA
IndustryLife Sciences Tools & Services
SizeLarge
Full Stock Analysis →
Illumina
NSQ:ILMN
77
CountryUSA
IndustryLife Sciences Tools & Services
SizeX-Large
Full Stock Analysis →
ADMA Biologics
NMQ:ADMA
97
CountryUSA
IndustryBiotechnology
SizeMedium
Full Stock Analysis →
Agilent
NYQ:A
89
CountryUSA
IndustryLife Sciences Tools & Services
SizeX-Large
Full Stock Analysis →
Pacific Biosciences of California
NSQ:PACB
16
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Cytek Biosciences
NSQ:CTKB
38
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →